EUVIMEDEUVIMED entdecken
Open Access

Aspirin Dosing Frequency and Dose Influence Thromboxane Suppression Despite Uniform Inhibition of Arachidonic Acid-induced Platelet Aggregation

John W Eikelboom iD, Sonia S Anand, Debi A Sloane, Jack Hirsh, Huyen A Tran, Qilong Yi, Jeffrey I Weitz

TH Open · 12.06.2026 · 10 (CP)

DOI: 10.1055/a-2885-2306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift TH Open, erschienen am 12.06.2026. Verfasst von John W Eikelboom und 6 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Research InstituteHamiltonOntarioCanada. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Incomplete thromboxane suppression with 81 mg aspirin daily is common and predicts higher vascular risk. We compared the effects of aspirin in controls and patients with cardiovascular disease and tested strategies to improve thromboxane suppression.

Methods

Two-phase randomized, open-label pharmacodynamic study. In Phase 1, controls and patients received enteric-coated (EC) aspirin 81 mg daily for 3 weeks. In Phase 2, the best responders within each cohort were randomized to EC aspirin 81 mg daily, EC aspirin 81 mg alternate daily, or soluble aspirin 81 mg daily, and the poorest responders to EC aspirin 81 mg daily, 325 mg daily, or 162 mg twice daily. Where results with EC and soluble aspirin 81 mg daily were similar, these arms were pooled for comparisons of daily versus alternate daily dosing. Outcome measures were light transmission aggregation in response to arachidonic acid, adenosine diphosphate, and collagen; serum thromboxane B2 (sTXB2); and urinary 11-dehydro-thromboxane B2 (uTXB2; creatinine-normalized).

Results

We enrolled 136 controls and 115 patients. Among controls, EC aspirin 81 mg daily suppressed platelet aggregation and reduced sTXB2 from 238.4 to 2.7 ng/mL and uTXB2 from 112.0 to 39.0 ng/mmol creatinine (all p < 0.0001). After 3 weeks, aggregation and serum thromboxane were similar in controls and patients but uTXB2 remained higher in patients (46.5 vs. 39.0, p = 0.004). In Phase 2, different aspirin formulations, doses, and dose frequencies did not materially affect platelet aggregation. In the best responders, EC and soluble aspirin had similar effects on thromboxane, but sTXB2 levels were higher with alternate daily versus daily dosing (pooled EC and soluble) in both controls (8.1 vs. 2.2 ng/mL, p = 0.005) and patients (5.2 vs. 1.7 ng/mL, p = 0.048). In the poorest responders, EC aspirin 162 mg twice daily produced the greatest suppression of both sTXB2 and uTXB2, with intermediate suppression with EC aspirin 325 mg daily and the least with EC aspirin 81 mg daily (all trend P values

Schlagwörter

Stichwörter der Autor:innen

aspirincardiovascular diseaseplatelet functionthromboxane

Autor:innen und Institutionen

  • Population Health Research InstituteHamiltonOntarioCanada.
  • The Thrombosis and Atherosclerosis Research InstituteHamiltonOntarioCanada.
  • Department of MedicineMcMaster UniversityHamiltonOntarioCanada.
  • Department of Clinical HaematologyAlfred HealthMelbourneVictoriaAustralia.
  • Department of Clinical HaematologyThe Australian Centre for Blood Diseases, Monash UniversityMelbourneVictoriaAustralia.
  • Department of Epidemiology and Community MedicineSchool of Epidemiology and Public Health, University of OttawaOttawaOntarioCanada.

ORCID-Profile: John W Eikelboom

Zitieren

APA

Eikelboom, J. W., Anand, S. S., Sloane, D. A., Hirsh, J., Tran, H. A., Yi, Q., & Weitz, J. I. (2026). Aspirin Dosing Frequency and Dose Influence Thromboxane Suppression Despite Uniform Inhibition of Arachidonic Acid-induced Platelet Aggregation. TH Open, 10(CP). https://doi.org/10.1055/a-2885-2306

Vancouver

Eikelboom JW, Anand SS, Sloane DA, Hirsh J, Tran HA, Yi Q, et al. Aspirin Dosing Frequency and Dose Influence Thromboxane Suppression Despite Uniform Inhibition of Arachidonic Acid-induced Platelet Aggregation. TH Open. 2026;10(CP). doi:10.1055/a-2885-2306

BibTeX
@article{Eikelboom2026,
  author = {Eikelboom, John W and Anand, Sonia S and Sloane, Debi A and Hirsh, Jack and Tran, Huyen A and Yi, Qilong and Weitz, Jeffrey I},
  title = {Aspirin Dosing Frequency and Dose Influence Thromboxane Suppression Despite Uniform Inhibition of Arachidonic Acid-induced Platelet Aggregation},
  journal = {TH Open},
  year = {2026},
  volume = {10},
  number = {CP},
  doi = {10.1055/a-2885-2306}
}
Kostenlos starten →